Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Other Accumulated Expenses (2018 - 2019)

CollPlant Biotechnologies filings provide 2 years of Other Accumulated Expenses readings, the most recent being $323000.0 for Q3 2019.

  • On a quarterly basis, Other Accumulated Expenses fell 37.64% to $323000.0 in Q3 2019 year-over-year; TTM through Sep 2019 was $323000.0, a 37.64% decrease, with the full-year FY2018 number at $334000.0, changed N/A from a year prior.
  • Other Accumulated Expenses hit $323000.0 in Q3 2019 for CollPlant Biotechnologies, up from $294000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.9 million in Q1 2018 to a low of $294000.0 in Q2 2019.